Loading…
Cytoplasmic initiation of cisplatin cytotoxicity
The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies...
Saved in:
Published in: | American Journal of Physiology. Renal Physiology 2008-07, Vol.295 (1), p.F44-F52 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453 |
---|---|
cites | cdi_FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453 |
container_end_page | F52 |
container_issue | 1 |
container_start_page | F44 |
container_title | American Journal of Physiology. Renal Physiology |
container_volume | 295 |
creator | Yu, Fang Megyesi, Judit Price, Peter M |
description | The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies have implicated both nuclear and cytoplasmic causes of cisplatin-induced death in cultured cells. We have demonstrated that cisplatin cytotoxicity depends on cdk2 activity, which is at least partly through the cdk2-E2F1 pathway. The mechanism of the dependency on cdk2, and whether cdk2 activation of E2F1 represents the only cell death pathway involved, is still unclear. Our previous work showed that deletion of the nuclear localization signal from p21 WAF1/CIP1, a cdk2 inhibitor, did not alter its protective action against cisplatin cytotoxicity. Active cdk2-cyclin complexes are localized in both the nucleus and cytoplasm, and it was reported that cdk2 translocated to the cytoplasm after an apoptotic stimulus. Herein, we show that cisplatin caused cell death in enucleated mouse kidney proximal tubule cells (TKPTS), which was prevented by cdk2 inhibition. Also, we localized cytoplasmic cdk2 to both the endoplasmic reticulum (ER) and Golgi compartments, and ER stress was blocked by specific cdk2 inhibition. We conclude that cisplatin can induce nuclear independent apoptosis, cisplatin cytotoxicity can be initiated by cytoplasmic events, and cytoplasmic cdk2 plays an important role in apoptosis signaling. |
doi_str_mv | 10.1152/ajprenal.00593.2007 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2494516</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1512871091</sourcerecordid><originalsourceid>FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453</originalsourceid><addsrcrecordid>eNpVkElLAzEYhoMotlZ_gSDF-9Tsy0WQ4gYFLwreQibNaMp0Miap2H9vaut2Ssi7fF8eAE4RnCDE8IVZ9NF1pp1AyBSZYAjFHhgWBVeIcr5f7oqgSjLxPABHKS0ghAhhdAgGSFIIJVdDAKfrHPrWpKW3Y9_57E32oRuHZmx9KkL23dgWTw4f3vq8PgYHjWmTO9mdI_B0c_04vatmD7f306tZZRmSuaKWGdWwWtA5w5I3HDMuaiVd4-bcFkFSLokQyDW1UxY6J5Qgbm65s5JRRkbgctvbr-pleXddjqbVffRLE9c6GK__K51_1S_hXWOqKEO8FJzvCmJ4W7mU9SKsYuGVNCYQ4fJ_XExka7IxpBRd8zMAQb2hrL8p6y_KekO5pM7-7vab2WEln0oKfHk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230120862</pqid></control><display><type>article</type><title>Cytoplasmic initiation of cisplatin cytotoxicity</title><source>American Physiological Society Free</source><creator>Yu, Fang ; Megyesi, Judit ; Price, Peter M</creator><creatorcontrib>Yu, Fang ; Megyesi, Judit ; Price, Peter M</creatorcontrib><description>The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies have implicated both nuclear and cytoplasmic causes of cisplatin-induced death in cultured cells. We have demonstrated that cisplatin cytotoxicity depends on cdk2 activity, which is at least partly through the cdk2-E2F1 pathway. The mechanism of the dependency on cdk2, and whether cdk2 activation of E2F1 represents the only cell death pathway involved, is still unclear. Our previous work showed that deletion of the nuclear localization signal from p21 WAF1/CIP1, a cdk2 inhibitor, did not alter its protective action against cisplatin cytotoxicity. Active cdk2-cyclin complexes are localized in both the nucleus and cytoplasm, and it was reported that cdk2 translocated to the cytoplasm after an apoptotic stimulus. Herein, we show that cisplatin caused cell death in enucleated mouse kidney proximal tubule cells (TKPTS), which was prevented by cdk2 inhibition. Also, we localized cytoplasmic cdk2 to both the endoplasmic reticulum (ER) and Golgi compartments, and ER stress was blocked by specific cdk2 inhibition. We conclude that cisplatin can induce nuclear independent apoptosis, cisplatin cytotoxicity can be initiated by cytoplasmic events, and cytoplasmic cdk2 plays an important role in apoptosis signaling.</description><identifier>ISSN: 1931-857X</identifier><identifier>ISSN: 0363-6127</identifier><identifier>EISSN: 1522-1466</identifier><identifier>DOI: 10.1152/ajprenal.00593.2007</identifier><identifier>PMID: 18400869</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Antineoplastic Agents - toxicity ; Apoptosis ; Binding sites ; Cell Compartmentation ; Cell culture ; Cell Nucleus - physiology ; Cells, Cultured ; Chemotherapy ; Cisplatin - toxicity ; Cyclin-Dependent Kinase 2 - antagonists & inhibitors ; Cyclin-Dependent Kinase 2 - metabolism ; Cytoplasm - physiology ; Deoxyribonucleic acid ; DNA ; Endoplasmic Reticulum - metabolism ; Golgi Apparatus - metabolism ; Kidney Tubules, Proximal - cytology ; Kidney Tubules, Proximal - drug effects ; Kidneys ; Mice ; Recombinant Fusion Proteins - metabolism</subject><ispartof>American Journal of Physiology. Renal Physiology, 2008-07, Vol.295 (1), p.F44-F52</ispartof><rights>Copyright American Physiological Society Jul 2008</rights><rights>Copyright © 2008, American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453</citedby><cites>FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,777,781,882,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18400869$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Fang</creatorcontrib><creatorcontrib>Megyesi, Judit</creatorcontrib><creatorcontrib>Price, Peter M</creatorcontrib><title>Cytoplasmic initiation of cisplatin cytotoxicity</title><title>American Journal of Physiology. Renal Physiology</title><addtitle>Am J Physiol Renal Physiol</addtitle><description>The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies have implicated both nuclear and cytoplasmic causes of cisplatin-induced death in cultured cells. We have demonstrated that cisplatin cytotoxicity depends on cdk2 activity, which is at least partly through the cdk2-E2F1 pathway. The mechanism of the dependency on cdk2, and whether cdk2 activation of E2F1 represents the only cell death pathway involved, is still unclear. Our previous work showed that deletion of the nuclear localization signal from p21 WAF1/CIP1, a cdk2 inhibitor, did not alter its protective action against cisplatin cytotoxicity. Active cdk2-cyclin complexes are localized in both the nucleus and cytoplasm, and it was reported that cdk2 translocated to the cytoplasm after an apoptotic stimulus. Herein, we show that cisplatin caused cell death in enucleated mouse kidney proximal tubule cells (TKPTS), which was prevented by cdk2 inhibition. Also, we localized cytoplasmic cdk2 to both the endoplasmic reticulum (ER) and Golgi compartments, and ER stress was blocked by specific cdk2 inhibition. We conclude that cisplatin can induce nuclear independent apoptosis, cisplatin cytotoxicity can be initiated by cytoplasmic events, and cytoplasmic cdk2 plays an important role in apoptosis signaling.</description><subject>Animals</subject><subject>Antineoplastic Agents - toxicity</subject><subject>Apoptosis</subject><subject>Binding sites</subject><subject>Cell Compartmentation</subject><subject>Cell culture</subject><subject>Cell Nucleus - physiology</subject><subject>Cells, Cultured</subject><subject>Chemotherapy</subject><subject>Cisplatin - toxicity</subject><subject>Cyclin-Dependent Kinase 2 - antagonists & inhibitors</subject><subject>Cyclin-Dependent Kinase 2 - metabolism</subject><subject>Cytoplasm - physiology</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Endoplasmic Reticulum - metabolism</subject><subject>Golgi Apparatus - metabolism</subject><subject>Kidney Tubules, Proximal - cytology</subject><subject>Kidney Tubules, Proximal - drug effects</subject><subject>Kidneys</subject><subject>Mice</subject><subject>Recombinant Fusion Proteins - metabolism</subject><issn>1931-857X</issn><issn>0363-6127</issn><issn>1522-1466</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNpVkElLAzEYhoMotlZ_gSDF-9Tsy0WQ4gYFLwreQibNaMp0Miap2H9vaut2Ssi7fF8eAE4RnCDE8IVZ9NF1pp1AyBSZYAjFHhgWBVeIcr5f7oqgSjLxPABHKS0ghAhhdAgGSFIIJVdDAKfrHPrWpKW3Y9_57E32oRuHZmx9KkL23dgWTw4f3vq8PgYHjWmTO9mdI_B0c_04vatmD7f306tZZRmSuaKWGdWwWtA5w5I3HDMuaiVd4-bcFkFSLokQyDW1UxY6J5Qgbm65s5JRRkbgctvbr-pleXddjqbVffRLE9c6GK__K51_1S_hXWOqKEO8FJzvCmJ4W7mU9SKsYuGVNCYQ4fJ_XExka7IxpBRd8zMAQb2hrL8p6y_KekO5pM7-7vab2WEln0oKfHk</recordid><startdate>20080701</startdate><enddate>20080701</enddate><creator>Yu, Fang</creator><creator>Megyesi, Judit</creator><creator>Price, Peter M</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20080701</creationdate><title>Cytoplasmic initiation of cisplatin cytotoxicity</title><author>Yu, Fang ; Megyesi, Judit ; Price, Peter M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Antineoplastic Agents - toxicity</topic><topic>Apoptosis</topic><topic>Binding sites</topic><topic>Cell Compartmentation</topic><topic>Cell culture</topic><topic>Cell Nucleus - physiology</topic><topic>Cells, Cultured</topic><topic>Chemotherapy</topic><topic>Cisplatin - toxicity</topic><topic>Cyclin-Dependent Kinase 2 - antagonists & inhibitors</topic><topic>Cyclin-Dependent Kinase 2 - metabolism</topic><topic>Cytoplasm - physiology</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Endoplasmic Reticulum - metabolism</topic><topic>Golgi Apparatus - metabolism</topic><topic>Kidney Tubules, Proximal - cytology</topic><topic>Kidney Tubules, Proximal - drug effects</topic><topic>Kidneys</topic><topic>Mice</topic><topic>Recombinant Fusion Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Fang</creatorcontrib><creatorcontrib>Megyesi, Judit</creatorcontrib><creatorcontrib>Price, Peter M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American Journal of Physiology. Renal Physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Fang</au><au>Megyesi, Judit</au><au>Price, Peter M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytoplasmic initiation of cisplatin cytotoxicity</atitle><jtitle>American Journal of Physiology. Renal Physiology</jtitle><addtitle>Am J Physiol Renal Physiol</addtitle><date>2008-07-01</date><risdate>2008</risdate><volume>295</volume><issue>1</issue><spage>F44</spage><epage>F52</epage><pages>F44-F52</pages><issn>1931-857X</issn><issn>0363-6127</issn><eissn>1522-1466</eissn><abstract>The mechanism of action of cisplatin as a chemotherapeutic agent has been attributed to DNA binding, while its mechanism of action as a nephrotoxin is unresolved. Only approximately 1% of intracellular cisplatin interacts with DNA, primarily forming intrastrand cross-linked adducts, and many studies have implicated both nuclear and cytoplasmic causes of cisplatin-induced death in cultured cells. We have demonstrated that cisplatin cytotoxicity depends on cdk2 activity, which is at least partly through the cdk2-E2F1 pathway. The mechanism of the dependency on cdk2, and whether cdk2 activation of E2F1 represents the only cell death pathway involved, is still unclear. Our previous work showed that deletion of the nuclear localization signal from p21 WAF1/CIP1, a cdk2 inhibitor, did not alter its protective action against cisplatin cytotoxicity. Active cdk2-cyclin complexes are localized in both the nucleus and cytoplasm, and it was reported that cdk2 translocated to the cytoplasm after an apoptotic stimulus. Herein, we show that cisplatin caused cell death in enucleated mouse kidney proximal tubule cells (TKPTS), which was prevented by cdk2 inhibition. Also, we localized cytoplasmic cdk2 to both the endoplasmic reticulum (ER) and Golgi compartments, and ER stress was blocked by specific cdk2 inhibition. We conclude that cisplatin can induce nuclear independent apoptosis, cisplatin cytotoxicity can be initiated by cytoplasmic events, and cytoplasmic cdk2 plays an important role in apoptosis signaling.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>18400869</pmid><doi>10.1152/ajprenal.00593.2007</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1931-857X |
ispartof | American Journal of Physiology. Renal Physiology, 2008-07, Vol.295 (1), p.F44-F52 |
issn | 1931-857X 0363-6127 1522-1466 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2494516 |
source | American Physiological Society Free |
subjects | Animals Antineoplastic Agents - toxicity Apoptosis Binding sites Cell Compartmentation Cell culture Cell Nucleus - physiology Cells, Cultured Chemotherapy Cisplatin - toxicity Cyclin-Dependent Kinase 2 - antagonists & inhibitors Cyclin-Dependent Kinase 2 - metabolism Cytoplasm - physiology Deoxyribonucleic acid DNA Endoplasmic Reticulum - metabolism Golgi Apparatus - metabolism Kidney Tubules, Proximal - cytology Kidney Tubules, Proximal - drug effects Kidneys Mice Recombinant Fusion Proteins - metabolism |
title | Cytoplasmic initiation of cisplatin cytotoxicity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T13%3A28%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytoplasmic%20initiation%20of%20cisplatin%20cytotoxicity&rft.jtitle=American%20Journal%20of%20Physiology.%20Renal%20Physiology&rft.au=Yu,%20Fang&rft.date=2008-07-01&rft.volume=295&rft.issue=1&rft.spage=F44&rft.epage=F52&rft.pages=F44-F52&rft.issn=1931-857X&rft.eissn=1522-1466&rft_id=info:doi/10.1152/ajprenal.00593.2007&rft_dat=%3Cproquest_pubme%3E1512871091%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c518t-4c5a9f5b74d5286f62567b98efed6cf5b84683771efbe9c0ee7973edc6ec85453%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=230120862&rft_id=info:pmid/18400869&rfr_iscdi=true |